Venclexta (venetoclax)

pCPA File Number: 22952

Negotiation Status:

Under consideration for negotiation

Indication(s):

in combination with obinutuzumab (VenO), for the subgroup of previously untreated CLL patients considered fit and potentially fludarabine-eligible

Sponsor/Manufacturer:

AbbVie Corporation

CDA-AMC Project Number:

PC0362-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable